{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:52:15Z","timestamp":1788187935289,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012456","name":"National Social Science Foundation of China","doi-asserted-by":"crossref","award":["20&ZD122"],"award-info":[{"award-number":["20&ZD122"]}],"id":[{"id":"10.13039\/501100012456","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Bidding for Selecting the Best Candidates, Guangzhou University of Chinese Medicine","award":["N\/A (https:\/\/www.gzucm.edu.cn\/)"],"award-info":[{"award-number":["N\/A (https:\/\/www.gzucm.edu.cn\/)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>During the COVID-19 pandemic, the Chinese government implemented nationwide public health interventions to control its spread. However, the impact of these measures on other infectious diseases remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The incidence of three types of notifiable infectious diseases in China were analyzed between 2013 and 2021. The seasonal Mann-Kendall test and Mann-Kendall mutation test were employed to examine trends and mutations in the time series. Based on the counterfactual inference, historical incidence rates were employed to construct SARIMA models and predict incidence between January 2020 and December 2021. Differences between reported and predicted incidences during the pandemic were compared using the Mann-Whitney U test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Between 2013 and 2019, the incidence rate of three types of notifiable infectious diseases fluctuated between 494.05\/100,000 and 550.62\/100,000. No discernible trend was observed for types A and B infectious diseases (Z = \u22121.344, <jats:italic>P<\/jats:italic>\u2009=\u20090.18). A significant upward trend was observed for type C infectious diseases (Z\u2009=\u20092.56, <jats:italic>P<\/jats:italic>\u2009=\u20090.01). In 2020, the overall incidence rate of three types of notifiable infectious diseases decreased to 367.08\/100,000. Compared to predicted values, the reported incidence of three types of infectious diseases was, on average, 30.05% lower in 2020 and 16.58% lower in 2021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The public health interventions implemented during the pandemic had a positive consequence on the prevention and control of other infectious diseases, with a particularly notable effect on type C infectious diseases. Among the diseases with different transmission routes, respiratory diseases and gastrointestinal or enteroviral diseases decreased significantly.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s44197-024-00273-x","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T19:09:31Z","timestamp":1722366571000},"page":"1191-1201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of the COVID-19 Pandemic on the Incidence of Notifiable Infectious Diseases in China Based on SARIMA Models Between 2013 and 2021"],"prefix":"10.1007","volume":"14","author":[{"given":"Jingwen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"issue":"1","key":"273_CR1","first-page":"1","volume":"4","author":"Standing up to infectious disease [J]","year":"2019","unstructured":"Standing up to infectious disease [J]. Nat Microbiol. 2019;4(1):1.","journal-title":"Nat Microbiol"},{"key":"273_CR2","doi-asserted-by":"publisher","first-page":"m1036","DOI":"10.1136\/bmj.m1036","volume":"368","author":"MAHASE E","year":"2020","unstructured":"Mahase E. Covid-19: WHO declares pandemic because of alarming levels of spread, severity, and inaction [J]. BMJ. 2020;368:m1036.","journal-title":"BMJ"},{"issue":"1","key":"273_CR3","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1038\/s41467-024-48201-8","volume":"15","author":"K LI","year":"2024","unstructured":"Li K, Rui J, Song W, et al. Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic [J]. Nat Commun. 2024;15(1):3891.","journal-title":"Nat Commun"},{"issue":"1","key":"273_CR4","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1038\/s41467-021-27292-7","volume":"12","author":"MJ GENG","year":"2021","unstructured":"Geng MJ, Zhang HY, Yu LJ, et al. Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic [J]. Nat Commun. 2021;12(1):6923.","journal-title":"Nat Commun"},{"issue":"7","key":"273_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/trstmh\/traa140","volume":"115","author":"AM BARNETT-HOWELL Z, WATSON O J, MOBAR","year":"2021","unstructured":"Barnett-Howell Z, Watson OJ, Mobarak AM. The benefits and costs of social distancing in high- and low-income countries [J]. Trans R Soc Trop Med Hyg. 2021;115(7):807\u201319.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"273_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","volume":"21","author":"C MARINGE","year":"2020","unstructured":"Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study [J]. Lancet Oncol. 2020;21(8):1023\u201334.","journal-title":"Lancet Oncol"},{"key":"273_CR7","doi-asserted-by":"crossref","unstructured":"Pati\u00f1o-Lugo D F, V\u00e9lez M, Vel\u00e1squez Salazarp, et al. Non-pharmaceutical interventions for containment, mitigation and suppression of COVID-19 infection [J]. Colomb Med (Cali). 2020;51(2):e4266.","DOI":"10.25100\/cm.v51i2.4266"},{"issue":"7825","key":"273_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-020-2293-x","volume":"585","author":"S LAI","year":"2020","unstructured":"Lai S, Ruktanonchai NW, Zhou L, et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China [J]. Nature. 2020;585(7825):410\u20133.","journal-title":"Nature"},{"issue":"1","key":"273_CR9","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1038\/s41467-021-23440-1","volume":"12","author":"L FENG","year":"2021","unstructured":"Feng L, Zhang T, Wang Q, et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States [J]. Nat Commun. 2021;12(1):3249.","journal-title":"Nat Commun"},{"key":"273_CR10","doi-asserted-by":"crossref","unstructured":"Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020 [J]. Am J Transplant. 2020;20(12):3681\u20135.","DOI":"10.1111\/ajt.16381"},{"key":"273_CR11","first-page":"100362","volume":"20","author":"Z ZHAO","year":"2022","unstructured":"Zhao Z, Zheng C, Qi H, et al. Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China [J]. Lancet Reg Health West Pac. 2022;20:100362.","journal-title":"Lancet Reg Health West Pac"},{"issue":"10","key":"273_CR12","doi-asserted-by":"publisher","first-page":"e0008719","DOI":"10.1371\/journal.pntd.0008719","volume":"14","author":"JT LIM","year":"2020","unstructured":"Lim JT, Dickens BSL, Chew LZX, et al. Impact of sars-cov-2 interventions on dengue transmission [J]. PLoS Negl Trop Dis. 2020;14(10):e0008719.","journal-title":"PLoS Negl Trop Dis"},{"key":"273_CR13","doi-asserted-by":"publisher","first-page":"e42820","DOI":"10.2196\/42820","volume":"9","author":"J ZHENG","year":"2023","unstructured":"Zheng J, Zhang N, Shen G, et al. Spatiotemporal and seasonal trends of Class A and B Notifiable Infectious diseases in China: retrospective analysis [J]. JMIR Public Health Surveill. 2023;9:e42820.","journal-title":"JMIR Public Health Surveill"},{"issue":"7820","key":"273_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2405-7","volume":"584","author":"S FLAXMAN","year":"2020","unstructured":"Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe [J]. Nature. 2020;584(7820):257\u201361.","journal-title":"Nature"},{"issue":"1","key":"273_CR15","doi-asserted-by":"publisher","first-page":"104881","DOI":"10.1016\/j.micinf.2021.104881","volume":"24","author":"HOUJ BAI B K, JIANG Q Y","year":"2022","unstructured":"Bai BK, Jiang QY, Hou J. The COVID-19 epidemic and other notifiable infectious diseases in China [J]. Microbes Infect. 2022;24(1):104881.","journal-title":"Microbes Infect"},{"key":"273_CR16","doi-asserted-by":"publisher","first-page":"728768","DOI":"10.3389\/fpubh.2021.728768","volume":"9","author":"B CHEN","year":"2021","unstructured":"Chen B, Wang M, Huang X, et al. Changes in incidence of notifiable infectious diseases in China under the Prevention and Control measures of COVID-19 [J]. Front Public Health. 2021;9:728768.","journal-title":"Front Public Health"},{"key":"273_CR17","unstructured":"Prevention CCFDCA. Overview of the national epidemic of notifiable infectious diseases in August 2021 [Z]. 2021."},{"issue":"7","key":"273_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1473-3099(17)30227-X","volume":"17","author":"S YANG","year":"2017","unstructured":"Yang S, Wu J, Ding C, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: an observational trend study [J]. Lancet Infect Dis. 2017;17(7):716\u201325.","journal-title":"Lancet Infect Dis"},{"key":"273_CR19","doi-asserted-by":"publisher","first-page":"e49400","DOI":"10.2196\/49400","volume":"25","author":"T LUO","year":"2023","unstructured":"Luo T, Zhou J, Yang J, et al. Early warning and prediction of Scarlet Fever in China using the Baidu Search Index and Autoregressive Integrated moving average with explanatory variable (ARIMAX) Model: Time Series Analysis [J]. J Med Internet Res. 2023;25:e49400.","journal-title":"J Med Internet Res"},{"key":"273_CR20","doi-asserted-by":"crossref","unstructured":"Wang C, Li Y, Feng W et al. Epidemiological Features and Forecast Model Analysis for the morbidity of Influenza in Ningbo, China, 2006\u20132014 [J]. Int J Environ Res Public Health, 2017, 14(6).","DOI":"10.3390\/ijerph14060559"},{"key":"273_CR21","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1017\/S0950268820000151","volume":"148","author":"Y CHEN","year":"2020","unstructured":"Chen Y, Leng K, Lu Y, et al. Epidemiological features and time-series analysis of influenza incidence in urban and rural areas of Shenyang, China, 2010\u20132018 [J]. Epidemiol Infect. 2020;148:e29.","journal-title":"Epidemiol Infect"},{"key":"273_CR22","doi-asserted-by":"publisher","first-page":"102348","DOI":"10.1016\/j.tmaid.2022.102348","volume":"48","author":"J NDEH N T, TESFALDET Y T, BUDNARD","year":"2022","unstructured":"Ndeh NT, Tesfaldet YT, Budnard J, et al. The secondary outcome of public health measures amidst the COVID-19 pandemic in the spread of other respiratory infectious diseases in Thailand [J]. Travel Med Infect Dis. 2022;48:102348.","journal-title":"Travel Med Infect Dis"},{"issue":"3","key":"273_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jhydrol.2007.11.009","volume":"349","author":"HAMED K H","year":"2008","unstructured":"Hamed KH. Trend detection in hydrologic data: the Mann\u2013Kendall trend test under the scaling hypothesis [J]. J Hydrol. 2008;349(3):350\u201363.","journal-title":"J Hydrol"},{"key":"273_CR24","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.lanepe.2021.100103","volume":"6","author":"A ULLRICH","year":"2021","unstructured":"Ullrich A, Schranz M, Rexroth U, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: an analysis of national surveillance data during week 1-2016 - week 32-2020 [J]. Lancet Reg Health Eur. 2021;6:100103.","journal-title":"Lancet Reg Health Eur"},{"key":"273_CR25","doi-asserted-by":"publisher","first-page":"760795","DOI":"10.3389\/fpubh.2021.760795","volume":"9","author":"M TUCZY\u0143SKA","year":"2021","unstructured":"Tuczy\u0144ska M, Matthews-Kozanecka M, Baum E. Accessibility to Non-COVID Health Services in the World during the COVID-19 pandemic: review [J]. Front Public Health. 2021;9:760795.","journal-title":"Front Public Health"},{"issue":"36","key":"273_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","volume":"69","author":"M CZEISLER","year":"2020","unstructured":"Czeisler M, Marynak K, Clarke KEN, et al. Delay or Avoidance of Medical Care because of COVID-19-Related concerns - United States, June 2020 [J]. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"273_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/hpm.2434","volume":"32","author":"H ZHANG","year":"2017","unstructured":"Zhang H, Wang L, Lai S, et al. Surveillance and early warning systems of infectious disease in China: from 2012 to 2014 [J]. Int J Health Plann Manage. 2017;32(3):329\u201338.","journal-title":"Int J Health Plann Manage"},{"key":"273_CR28","doi-asserted-by":"crossref","unstructured":"Adegbija O, Walker J, Smoll N et al. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia [J]. Commun Dis Intell (2018), 2021, 45.","DOI":"10.33321\/cdi.2021.45.11"},{"issue":"5","key":"273_CR29","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/cid\/ciab529","volume":"74","author":"MA CRANE","year":"2022","unstructured":"Crane MA, Popovic A, Panaparambil R, et al. Reporting of infectious diseases in the United States during the Coronavirus Disease 2019 (COVID-19) pandemic [J]. Clin Infect Dis. 2022;74(5):901\u20134.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"273_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40249-023-01066-3","volume":"12","author":"W ZHANG","year":"2023","unstructured":"Zhang W, Wu Y, Wen B, et al. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study [J]. Infect Dis Poverty. 2023;12(1):15.","journal-title":"Infect Dis Poverty"},{"issue":"6491","key":"273_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1126\/science.abb6105","volume":"368","author":"H TIAN","year":"2020","unstructured":"Tian H, Liu Y, Li Y, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China [J]. Science. 2020;368(6491):638\u201342.","journal-title":"Science"},{"key":"273_CR32","doi-asserted-by":"publisher","first-page":"101686","DOI":"10.1016\/j.tmaid.2020.101686","volume":"37","author":"J CHEN","year":"2020","unstructured":"Chen J, Feng ZH, Ye L, et al. Travel rush during Chinese Spring Festival and the 2019-nCoV [J]. Travel Med Infect Dis. 2020;37:101686.","journal-title":"Travel Med Infect Dis"},{"key":"273_CR33","doi-asserted-by":"publisher","first-page":"1251683","DOI":"10.3389\/fmicb.2023.1251683","volume":"14","author":"X ZHOU","year":"2023","unstructured":"Zhou X, Qian K, Zhu C, et al. Surveillance, epidemiology, and impact of the coronavirus disease 2019 interventions on the incidence of enterovirus infections in Nanchang, China, 2010\u20132022 [J]. Front Microbiol. 2023;14:1251683.","journal-title":"Front Microbiol"},{"key":"273_CR34","doi-asserted-by":"publisher","first-page":"e068302","DOI":"10.1136\/bmj-2021-068302","volume":"375","author":"S TALIC","year":"2021","unstructured":"Talic S, Shah S, Wild H, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis [J]. BMJ. 2021;375:e068302.","journal-title":"BMJ"},{"issue":"1","key":"273_CR35","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1186\/s12889-021-11630-x","volume":"21","author":"A SENT\u00edS","year":"2021","unstructured":"Sent\u00eds A, Prats-Uribe A, L\u00f3pez-Corbeto E, et al. The impact of the COVID-19 pandemic on sexually transmitted infections surveillance data: incidence drop or artefact? [J]. BMC Public Health. 2021;21(1):1637.","journal-title":"BMC Public Health"},{"issue":"3","key":"273_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/QAI.0000000000002462","volume":"85","author":"MA HAMMOUD","year":"2020","unstructured":"Hammoud MA, Maher L, Holt M, et al. Physical distancing due to COVID-19 disrupts sexual behaviors among Gay and Bisexual men in Australia: implications for trends in HIV and other sexually transmissible infections [J]. J Acquir Immune Defic Syndr. 2020;85(3):309\u201315.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-024-00273-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T21:09:53Z","timestamp":1727730593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-024-00273-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1007\/s44197-024-00273-x","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"26 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No Ethics Approval needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors have read and approved the submitted manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}